Galapagos | GLPG - Debt



Galapagos reported EUR10.86M in Debt for its fiscal quarter ending in March of 2025.


Debt Change Date
argenx SE 43.15M 4.1M Jun/2025
AstraZeneca USD 32.84B 1.19B Jun/2025
Biogen USD 6.59B 296.8M Jun/2025
Genmab DKK 148M 5M Jun/2025
Gilead Sciences USD 24.95B 6M Jun/2025
GlaxoSmithKline GBP 17.35B 1.08B Jun/2025
GRIFOLS EUR 8.82B 1.23B Jun/2025
Hikma Pharmaceutical USD 1.31B 30M Dec/2024
Incyte USD 42.41M 5.29M Jun/2025
Merck EUR 9.4B 704M Jun/2025
Neurocrine Biosciences USD 439.1M 8.4M Jun/2025
Novartis USD 31.27B 12M Mar/2025
Roche Holding CHF 34.44B 5.23B Jun/2024
Sanofi 22.28B 1.24B Jun/2025
UCB EUR 3.03B 12M Dec/2024
Vertex Pharmaceuticals USD 1.53B 121.7M Jun/2025